bioAffinity Technologies validation trial for non-invasive lung cancer test results in high sensitivity and specificity
Trial results of automated test demonstrate non-invasive CyPath Lung is highly accurate in finding lung cancer
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
11 Jun 20
Trial results of automated test demonstrate non-invasive CyPath Lung is highly accurate in finding lung cancer
10 Jun 20
The CRO has applied its clinical assay and diagnostics capabilities to address a breadth of sponsor and employer…
09 Jun 20
The system has been tested in simulated lung environments and recently received Emergency Use Authorization (EUA) from the…
08 Jun 20
According to CDC's recommendations, decontaminated respirators should only be used when new FDA-cleared N95 respirators, NIOSH-approved N95 respirators,…
05 Jun 20
Move comes as public health authorities and governments worldwide identify high flow nasal cannula systems as first-line therapy…
The majority of surgeries have been given less priority due to Covid-19, while other medical device markets have…
03 Jun 20
The CE mark approval allows commercialisation of ReddyPort Elbow across the European Union (EU) and other CE Mark…
02 Jun 20
Quanta is providing the NHS with essential protective equipment, such as semi-reusable surgical mask adapters and face shield…
01 Jun 20
The VITAL is a high-pressure ventilator designed to use only one-seventh of the parts used in a traditional…
29 May 20
Cellulotech's Specially-Treated Paper Passes Fluid Resistance Test, Advancing Company Vision to Transform the Protective Mask Industry